The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

zeopane.com

About Zeopane Microneedles

Zeopane Microneedles is a Hong Kong based company that designs and markets Zeolite micro-needles and insulin delivery patches for diabetes patients.

Zeopane Microneedles Headquarter Location

Hong Kong

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Zeopane Microneedles

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Zeopane Microneedles is included in 1 Expert Collection, including Diabetes.

D

Diabetes

1,750 items

  • Who are Zeopane Microneedles's competitors?

    Competitors of Zeopane Microneedles include Vapotherm, Avalon Laboratories, Tandem Diabetes Care, SpineAlign Medical, Visiogen and 10 more.

You May Also Like

R
Revascular Therapeutics

ReVascular Therapeutics has pioneered advances in technology for the intravascular treatment of complex lesions and total occlusions that typically cannot be treated using current catheter-based technologies and products.

M
M2 Group Holdings

M2 Group Holdings is developing a disposable drug delivery system which will initially be used for the treatment of Type I diabetes.

E
Exogenesis

Exogenesis uses atomic scale processing techniques to manufacture medical devices.

C
C2C

C2C is a medical device company developing a portfolio of medical devices.

D
Dialysis Systems

Dialysis Systems Inc., based in Nashville, Tennessee, designs, manufactures and markets fluid purification, treatment and delivery systems for dialysis clinics and other medical facilities.

Embolx Logo
Embolx

Embolx is a commercial-stage medical device company developing microcatheters for arterial embolization procedures. The Sniper balloon occlusion microcatheter aims to set a new standard for precise embolic delivery and target filling by controlling pressure to direct blood flow while protecting non-target surrounding tissues.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.